16 October 2025 The court rejected Novartis’s request for emergency measures against a Spanish importer after the pharma company failed to meet the test to enforce an injunction, the winning lawyers told LSIPR.
15 October 2025
14 October 2025
Latest Features
Europe
As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.
Americas
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US.
Americas
In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation.
Biotechnology
Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.
Americas
With growing legislation, research and demand for medical use, cannabis presents an economic opportunity for the Caribbean—but IP rights in the region have some way to go, write Keesha Fleming Lake of Keesha Fleming Lake, and Rachael Lodge Corrie of Foga Daley.
Americas
From setting a clear overall strategy to drafting high-quality claims, Christopher Wheeler and Gerald Murphy of Birch, Stewart, Kolasch & Birch explain how to reduce patent prosecution expenditure and obtain better IP protection.
Asia
Hui Zhuang of CCPIT Patent and Trademark Law Office discusses several strategies to increase the chance of pharmaceutical or food trademarks that include ingredients being registered.
Americas
A procedural change at the Patent Trial and Appeal Board offers petitioners a valuable tool to push back against Fintiv-based discretionary denial, writes Taylor Stemler of Merchant & Gould.
More News
14 October 2025 Hire brings experience across the pharmaceutical, medtech, cosmetics, and food sectors, advising clients on regulatory, policy, and compliance matters before UK and EU authorities.
13 October 2025 A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in startups, and threaten technology transfers.
10 October 2025 A new report highlights widespread mental health issues among legal professionals, leading to poor wellbeing and career disillusionment.
9 October 2025 The pharma giant extends market exclusivity for a top-selling drug accounting for nearly half of its multi-billion-dollar sales.
9 October 2025 The promises and pitfalls of AI took centre stage at CIPA’s annual congress in Bristol this week, as Sarah Speight reports.
9 October 2025 The hire brings experience managing global trademark, copyright, and domain portfolios, as well as prior in-house roles at Teva and Johnson & Johnson.
8 October 2025 A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies. Juliana Neves of Licks explains the key changes, upcoming reforms, and how companies can protect their portfolios effectively.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox